Lawmakers are proposing a few tweaks to Minnesota's medical marijuana law.
Patients suffering from inflammatory bowel disease — now shut out of the program — could legally enroll with the Office of Medical Cannabis if the House and Senate agree. The program is already open to patients with Crohn's disease — one type of IBD — but not patients with related conditions such as ulcerative colitis.
It's a small change, but one that Dr. Kyle Kingsley, CEO of cannabis manufacturer Minnesota Medical Solutions, hopes will give more people access to a program that has struggled with low enrollment and high prices.
As of Friday, the state had enrolled 1,190 medical cannabis patients.
Read more
